{{Drugbox
| type              = combo
| drug_name         = Tetrabamate
| component1        = Febarbamate
| class1            = Carbamate
| component2        = Difebarbamate
| class2            = Carbamate
| component3        = Phenobarbital
| class3            = Barbiturate
| ChEMBL = 1909287
}}

'''Tetrabamate''' ('''Atrium''', '''G Tril''', '''Sevrium''') is a [[combination drug]] [[drug formulation|formulation]] of [[febarbamate]], [[difebarbamate]], and [[phenobarbital]] which was marketed in [[France]] and [[Spain]] and was used to treat [[anxiety]] and [[alcohol withdrawal]]-associated [[muscle tremor]]s, [[psychomotor agitation|agitation]], and [[major depression|depression]].<ref name="Index nominum 2000: international drug directory">{{cite book | title = Index nominum 2000: international drug directory | url = http://books.google.com/books?id=5GpcTQD_L2oC&pg=PA333 | accessdate = 26 November 2011 | year = 2000 | publisher = Taylor & Francis US | isbn = 978-3-88763-075-1 | pages = 333 & 427}}</ref><ref name="SchiffMaddrey2011">{{cite book | author1 = Eugene R. Schiff | author2 = Willis C. Maddrey | author3 = Michael F. Sorrell | title = Schiff's Diseases of the Liver | url = http://books.google.com/books?id=HsxFSx_B4sUC&pg=PT2276 | accessdate = 26 November 2011 | date = 19 October 2011 | publisher = John Wiley and Sons | isbn = 978-1-119-95048-6 | page = 2276}}</ref><ref name="pmid7761807">{{cite journal | author = Binder D, Jost R, Flury R, Salomon F | title = [Acute liver failure following tetrabamate] | language = German | journal = Schweizerische Medizinische Wochenschrift | volume = 125 | issue = 19 | pages = 965–9 | year = 1995 | month = May | pmid = 7761807 | doi = | url = }}</ref><ref name="Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by governments">{{cite book | title = Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by governments | url = http://books.google.com/books?id=leVCukUgNlsC&pg=PA259 | accessdate = 26 November 2011 | year = 2003 | publisher = United Nations Publications | isbn = 978-92-1-130230-1 | pages = 259}}</ref> It was largely, but not completely [[List of withdrawn drugs|discontinued]] on April 4, 1997 after over 30 years of use due to reports of [[hepatitis]] and [[acute liver failure]].<ref name="pmid7761807" /><ref name="Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by governments" /><ref name="pmid7699230">{{cite journal | author = Horsmans Y, Lannes D, Pessayre D, Larrey D | title = Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamate | journal = Journal of Hepatology | volume = 21 | issue = 6 | pages = 1075–9 | year = 1994 | month = December | pmid = 7699230 | doi = | url = }}</ref><ref name="pmid11824432">{{cite journal | author = | title = Severe hepatitis due to Atrium | journal = Prescrire International | volume = 10 | issue = 55 | pages = 150 | year = 2001 | month = October | pmid = 11824432 | doi = | url = }}</ref> The decision to restrict the use of the drug had been long-awaited.<ref name="pmid11824432" />

== References ==
{{Reflist}}


{{Antiaddictives}}
{{Anxiolytics}}
{{Muscle relaxants}}
{{Sedatives}}
{{GABAAergics}}

[[Category:Anxiolytics]]
[[Category:Barbiturates]]
[[Category:Carbamates]]
[[Category:Drug rehabilitation]]
[[Category:Muscle relaxants]]
[[Category:Sedatives]]
[[Category:Withdrawn drugs]]
[[Category:Combination drugs]]